Freeze-Dried Composition of Inactivated Virus Envelope with Membrane Fusion Activity
Abstract
The objects of the present invention are to provide a freeze-dried composition of an inactivated virus envelop having membrane fusion activity which can be stored at higher temperatures without losing the ability to introduce foreign matters and to provide a method of introducing a foreign matter into a cell with high efficiency. The present invention provides a freeze-dried composition for introducing a foreign matter which comprises an inactivated virus envelope having membrane fusion activity, and at least one stabilizer selected from the group consisting of a protein hydrolysate, leucine, an L-arginine-acid and a polysaccharide, and a method of introducing a foreign matter using the freeze-dried composition containing an inactivated virus envelope.
Claims
exact text as granted — not AI-modified1 . A freeze-dried composition comprising an inactivated virus envelope having membrane fusion activity, and at least one stabilizer selected from the group consisting of a protein hydrolysate, leucine, an L-arginine-acid and a polysaccharide.
2 . The freeze-dried composition according to claim 1 , wherein the inactivated virus envelope is an inactivated virus envelope of a virus of Paramyxoviridae, Orthomyxoviridae, Herpesviridae, Hepadnaviridae or Flaviviridae.
3 . The freeze-dried composition according to claim 1 or 2 , wherein the stabilizer is a protein hydrolysate and a polysaccharide.
4 . The freeze-dried composition according to any one of claims 1 to 3 , which is prepared by a process comprising a step (1) of mixing a suspension of the inactivated virus envelope having membrane fusion activity and the stabilizer and a step (2) of freeze-drying the mixture obtained in the step (1).
5 . The freeze-dried composition according to claim 4 , wherein the concentration of the inactivated virus envelope in the mixture obtained in the step (1) corresponds to an OD of from 0.1 to 7.0.
6 . The freeze-dried composition according to claim 4 or 5 , wherein the concentration of the protein hydrolysate, leucine or the L-arginine-acid in the mixture obtained in the step (1) is from 0.1 to 2.5%.
7 . The freeze-dried composition according to any one of claims 4 to 6 , wherein the concentration of the polysaccharide in the mixture obtained in the step (1) is from 0.05 to 0.5%.
8 . The freeze-dried composition according to any one of claims 4 to 7 , wherein the salt concentration in the mixture obtained in the step (1) is at most 3 mM.
9 . A method of introducing a foreign matter into a cell or a living organism, which comprises:
(1) a step of rehydrating a freeze-dried composition containing an inactivated virus envelope having membrane fusion activity with a mixture comprising the foreign matter and water, and
(2) a step of bringing the composition obtained in the step (1) into contact with the cell or the living organism.
10 . The method of introducing a foreign matter according to claim 9 , wherein the freeze-dried composition is the freeze-dried composition as defined in any one of claims 1 to 8 .
11 . A cell fusion method comprising:
(a) step of rehydrating a freeze-dried composition containing an inactivated virus envelope having membrane fusion activity; and
(b) step of mixing the composition obtained in the step (a) with a suspension of cells to be fused.
12 . The cell fusion method according to claim 11 , wherein the freeze-dried composition is the freeze-dried composition as defined in any one of claims 1 to 8 .Join the waitlist — get patent alerts
Track US2008102524A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.